Miller Dave A, DiNunzio James C, Yang Wei, McGinity James W, Williams Robert O
College of Pharmacy, University of Texas at Austin, Austin, Texas 78712, USA.
Drug Dev Ind Pharm. 2008 Aug;34(8):890-902. doi: 10.1080/03639040801929273.
Previous attempts to improve the dissolution and absorption properties of itraconazole (ITZ) through advanced formulation design have focused only on release in acidic media; however, recent reports indicate that absorption occurs primarily in the proximal small intestine. This suggests that enhancing supersaturation of ITZ in neutral aqueous environments is essential for improving absorption. The aim of this study was to evaluate different polymeric stabilizers with either immediate release (IR) (Methocel E5, Methocel E50, Kollidon 12, and Kollidon 90) or enteric release (EUDRAGIT L 100-55, HP-55, and HP-55S) properties to determine the chemical and physical attributes of the polymeric stabilizers that promote supersaturation of ITZ in neutral media. Each amorphous composition was produced by hot-melt extrusion and characterized by differential scanning calorimetry. Dissolution testing by a supersaturated acidic-to-neutral pH change method was conducted on each composition. Testing of IR compositions revealed that Methocel was a superior stabilizer compared with Kollidon owing to stronger intermolecular interaction with ITZ molecules in solution. Increasing the molecular weight of polymers was found to promote ITZ supersaturation and was most likely attributable to increased solution viscosity resulting in retention of ITZ molecules in an enthalpically favored association with the polymer for extended durations. Of the enteric polymeric stabilizers, EUDRAGIT L 100-55 was found to be superior to both HP-55 grades because of its greater permeability to acid that allowed for improved hydration of ITZ in the acid phase as well as a greater number of free hydroxyl groups on the polymer backbone that presumably helped to stabilize ITZ in solution. The Methoceltrade mark E50 and EUDRAGIT L 100-55 formulations were evaluated for in vivo drug absorption in male Sprague-Dawley rats and were found to produce a threefold greater ITZ absorption over our previously reported IR formulations. The results of this study confirmed the hypothesis that supersaturation of ITZ following an acidic-to-neutral pH transition in vitro correlates directly to in vivo absorption.
以往通过先进的制剂设计来改善伊曲康唑(ITZ)溶解和吸收特性的尝试仅聚焦于在酸性介质中的释放;然而,最近的报告表明吸收主要发生在近端小肠。这表明提高ITZ在中性水性环境中的过饱和度对于改善吸收至关重要。本研究的目的是评估具有速释(IR)(甲基纤维素E5、甲基纤维素E50、聚乙烯吡咯烷酮12和聚乙烯吡咯烷酮90)或肠溶释放(丙烯酸树脂L 100 - 55、HP - 55和HP - 55S)特性的不同聚合物稳定剂,以确定促进ITZ在中性介质中过饱和的聚合物稳定剂的化学和物理属性。每种无定形组合物通过热熔挤出制备,并通过差示扫描量热法进行表征。对每种组合物采用过饱和酸性至中性pH变化方法进行溶出度测试。对IR组合物的测试表明,与聚乙烯吡咯烷酮相比,甲基纤维素是一种更优异的稳定剂,这是因为其在溶液中与ITZ分子的分子间相互作用更强。发现增加聚合物的分子量可促进ITZ过饱和,这很可能归因于溶液粘度增加,导致ITZ分子在焓有利的情况下与聚合物长时间缔合。在肠溶聚合物稳定剂中,发现丙烯酸树脂L 100 - 55优于两种HP - 55牌号,因为它对酸的渗透性更高,这使得ITZ在酸相中水合作用更好,并且聚合物主链上有更多的游离羟基,推测这有助于在溶液中稳定ITZ。对甲基纤维素商标E50和丙烯酸树脂L 100 - 55制剂在雄性Sprague - Dawley大鼠体内的药物吸收进行了评估,发现与我们之前报道的IR制剂相比,它们使ITZ的吸收提高了三倍。本研究结果证实了以下假设:体外酸性至中性pH转变后ITZ的过饱和度与体内吸收直接相关。